Long non-coding RNA is a type of gene that is longer than 200 nt and does not encode protein structural changes. Long non-coding RNA can interact with DNA and mRNA, regulate protein interaction expression, and regulate biological processes.
The global Long Non-coding RNA Sequencing (lncRNA-seq) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Long Non-coding RNA Sequencing (lncRNA-seq) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long Non-coding RNA Sequencing (lncRNA-seq) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Long Non-coding RNA Sequencing (lncRNA-seq) in Developmental Biology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Long Non-coding RNA Sequencing (lncRNA-seq) include Aksomics, Anshengda, BGI, Annuoyouda Gene Technology, LC Sciences, Creative Biolabs, Eurofins Scientific, CD Genomics, Novogene, Beijing Compson Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Long Non-coding RNA Sequencing (lncRNA-seq), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long Non-coding RNA Sequencing (lncRNA-seq).
The Long Non-coding RNA Sequencing (lncRNA-seq) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Long Non-coding RNA Sequencing (lncRNA-seq) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long Non-coding RNA Sequencing (lncRNA-seq) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aksomics
Anshengda
BGI
Annuoyouda Gene Technology
LC Sciences
Creative Biolabs
Eurofins Scientific
CD Genomics
Novogene
Beijing Compson Biotechnology Co., Ltd.
Biomark Biotechnology
BD
10x Genomics
Majorbio
QIAGEN
Roche
Segment by Type
Equipment Supplies
Service
Segment by Application
Developmental Biology
Oncology
Neuroscience
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long Non-coding RNA Sequencing (lncRNA-seq) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment Supplies
1.2.3 Service
1.3 Market by Application
1.3.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Developmental Biology
1.3.3 Oncology
1.3.4 Neuroscience
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Perspective (2019-2030)
2.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Growth Trends by Region
2.2.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Long Non-coding RNA Sequencing (lncRNA-seq) Historic Market Size by Region (2019-2024)
2.2.3 Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Region (2025-2030)
2.3 Long Non-coding RNA Sequencing (lncRNA-seq) Market Dynamics
2.3.1 Long Non-coding RNA Sequencing (lncRNA-seq) Industry Trends
2.3.2 Long Non-coding RNA Sequencing (lncRNA-seq) Market Drivers
2.3.3 Long Non-coding RNA Sequencing (lncRNA-seq) Market Challenges
2.3.4 Long Non-coding RNA Sequencing (lncRNA-seq) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Non-coding RNA Sequencing (lncRNA-seq) Players by Revenue
3.1.1 Global Top Long Non-coding RNA Sequencing (lncRNA-seq) Players by Revenue (2019-2024)
3.1.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue Market Share by Players (2019-2024)
3.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Long Non-coding RNA Sequencing (lncRNA-seq) Revenue
3.4 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Concentration Ratio
3.4.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Non-coding RNA Sequencing (lncRNA-seq) Revenue in 2023
3.5 Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq) Head office and Area Served
3.6 Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq), Product and Application
3.7 Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Non-coding RNA Sequencing (lncRNA-seq) Breakdown Data by Type
4.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Historic Market Size by Type (2019-2024)
4.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Type (2025-2030)
5 Long Non-coding RNA Sequencing (lncRNA-seq) Breakdown Data by Application
5.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Historic Market Size by Application (2019-2024)
5.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2019-2030)
6.2 North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2019-2024)
6.4 North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2019-2030)
7.2 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2019-2024)
7.4 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2019-2030)
8.2 Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (2019-2024)
8.4 Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2019-2030)
9.2 Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2019-2024)
9.4 Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2019-2030)
10.2 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2019-2024)
10.4 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aksomics
11.1.1 Aksomics Company Details
11.1.2 Aksomics Business Overview
11.1.3 Aksomics Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.1.4 Aksomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.1.5 Aksomics Recent Development
11.2 Anshengda
11.2.1 Anshengda Company Details
11.2.2 Anshengda Business Overview
11.2.3 Anshengda Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.2.4 Anshengda Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.2.5 Anshengda Recent Development
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.3.4 BGI Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.3.5 BGI Recent Development
11.4 Annuoyouda Gene Technology
11.4.1 Annuoyouda Gene Technology Company Details
11.4.2 Annuoyouda Gene Technology Business Overview
11.4.3 Annuoyouda Gene Technology Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.4.4 Annuoyouda Gene Technology Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.4.5 Annuoyouda Gene Technology Recent Development
11.5 LC Sciences
11.5.1 LC Sciences Company Details
11.5.2 LC Sciences Business Overview
11.5.3 LC Sciences Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.5.4 LC Sciences Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.5.5 LC Sciences Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Details
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.6.4 Creative Biolabs Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.6.5 Creative Biolabs Recent Development
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Details
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.7.4 Eurofins Scientific Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.7.5 Eurofins Scientific Recent Development
11.8 CD Genomics
11.8.1 CD Genomics Company Details
11.8.2 CD Genomics Business Overview
11.8.3 CD Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.8.4 CD Genomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.8.5 CD Genomics Recent Development
11.9 Novogene
11.9.1 Novogene Company Details
11.9.2 Novogene Business Overview
11.9.3 Novogene Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.9.4 Novogene Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.9.5 Novogene Recent Development
11.10 Beijing Compson Biotechnology Co., Ltd.
11.10.1 Beijing Compson Biotechnology Co., Ltd. Company Details
11.10.2 Beijing Compson Biotechnology Co., Ltd. Business Overview
11.10.3 Beijing Compson Biotechnology Co., Ltd. Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.10.4 Beijing Compson Biotechnology Co., Ltd. Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.10.5 Beijing Compson Biotechnology Co., Ltd. Recent Development
11.11 Biomark Biotechnology
11.11.1 Biomark Biotechnology Company Details
11.11.2 Biomark Biotechnology Business Overview
11.11.3 Biomark Biotechnology Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.11.4 Biomark Biotechnology Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.11.5 Biomark Biotechnology Recent Development
11.12 BD
11.12.1 BD Company Details
11.12.2 BD Business Overview
11.12.3 BD Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.12.4 BD Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.12.5 BD Recent Development
11.13 10x Genomics
11.13.1 10x Genomics Company Details
11.13.2 10x Genomics Business Overview
11.13.3 10x Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.13.4 10x Genomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.13.5 10x Genomics Recent Development
11.14 Majorbio
11.14.1 Majorbio Company Details
11.14.2 Majorbio Business Overview
11.14.3 Majorbio Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.14.4 Majorbio Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.14.5 Majorbio Recent Development
11.15 QIAGEN
11.15.1 QIAGEN Company Details
11.15.2 QIAGEN Business Overview
11.15.3 QIAGEN Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.15.4 QIAGEN Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.15.5 QIAGEN Recent Development
11.16 Roche
11.16.1 Roche Company Details
11.16.2 Roche Business Overview
11.16.3 Roche Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.16.4 Roche Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2019-2024)
11.16.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Aksomics
Anshengda
BGI
Annuoyouda Gene Technology
LC Sciences
Creative Biolabs
Eurofins Scientific
CD Genomics
Novogene
Beijing Compson Biotechnology Co., Ltd.
Biomark Biotechnology
BD
10x Genomics
Majorbio
QIAGEN
Roche
听
听
*If Applicable.
